Toggle Dropdown
Groups
Announcements
Projects
Ideas
Welcome guest
Log in
Friends
Loading
Loading...
https://finance.yahoo.com/news/chroma-medicine-presents-preclinical-vivo-150000625.html
0
0
Chroma Medicine Presents Preclinical In Vivo Data Showing Durable Cholesterol Reduction with a PCSK9-Targeted Epigenetic Editor at the 2023 AHA Scientific Sessions - Yahoo Finance
11/11/23 at 3:00pm
Organization
Yahoo Entertainment
Author
PR Newswire
44 words
0
Comments
Chroma Medicine, Inc., (Chroma) a genomic medicine company pioneering single-dose epigenetic editing therapeutics, today presented new preclinical data...
Science
Health
Chroma Medicine Presents Preclinical In Vivo Data
Epigenetic Editor
PCSK9
editing therapeutics
AHA Scientific Sessions - Yahoo Finance Chroma Medicine, Inc.
genomic medicine company
You are the first to view
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...